Microrna-149 inhibits proliferation and invasion of glioma cells via blockade of akt1 signaling

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 871-881

  Pan, S J ^a   Zhan, S K ^a   Pei, B G ^b   Sun, Q F ^a   Bian, L G ^a   Sun, Bo Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chaoyang Hospital   (China)

Author keywords

AKT1; Glioma; Invasion; MicroRNA 149; Proliferation

Indexed keywords

AKT1 PROTEIN; CYCLIN D1; CYCLINE; GELATINASE A; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 149; PROTEIN; UNCLASSIFIED DRUG; MATRIX METALLOPROTEINASE; PROTEIN AKT1; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING; FEMALE; GLIOBLASTOMA; MTT ASSAY; SURVIVAL;

EID: 84873035767     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500405     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Shimoji K, Miyajima M, Karagiozov K, et al. Surgical considerations in fourth ventricular ependymoma with the transcerebellomedullary fissure approach in focus. Childs Nerv Syst 2009; 25:1221-8.
3. Mascarenhas F, Matos JA, Ortiz M, et al. Radiotherapy in supratentorial low grade gliomas. Acta Med Port 2002; 15:451-9.
4. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359:1011-18.
5. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31.
6. Zhang M, Jin M, Yu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care 2012; 21:274-80.
7. Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30:79-84.
8. Mw Z, Mj J, Yx Y, et al. Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk. Mol Carcinog 2011; 51(S)1:E21-31.
9. Liu Z, Li G, Wei S, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010; 116:4753-60.
10. Vinci S, Gelmini S, Pratesi N, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 2011; 49:2073-80.
11. Zhang MW, Yu YX, Jin MJ, et al. Association of miR-605 and miR-149 genetic polymorphisms with related risk factors of lung cancer susceptibility. Zhejiang Da Xue Xue Bao Yi Xue Ban 2011; 40:265-71.
12. Zinda MJ, Johnson MA, Paul JD, et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res 2001; 7:2475-9.
13. Wlodarski P, Grajkowska W, lojek M, et al. Activation of Akt and Erk pathways in medulloblastoma. Folia Neuropathol 2006; 44:214-20.
14. Schlegel J, Piontek G, Budde B, et al. The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Cancer Lett 2000; 158:103-8.
15. Wang Y, Wang X, Zhang J, et al. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas. J Neurooncol 2012; 106:217-24.
16. Kefas B, Godlewski J, Comeau L, et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68:3566-72.
17. Tian Y, Nan Y, Han L, et al. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol 2012; 40:1105-12.
18. Lin RJ, Lin YC, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 2010; 49:719-27.
19. Hanahan D and Weinberg RA: The hallmarks of cancer: the next generation. Cell 2011; 144:646-674.
20. Li D, Chen P, Li XY, et al. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 2011; 15:673-82.
21. Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010; 126:1166-76.
22. Liu H, Brannon AR, Reddy AR, et al. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 2010; 4:51.
23. Luo Z, Zhang L, Li Z, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics 2012; 5:3.
24. Jin L, Hu WL, Jiang CC, et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108:15840-5.
25. Zhang J, Zhang QY, Fu YC, et al. Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo. Technol Cancer Res Treat 2009; 8:467-78.
26. Fu Y, Zhang Q, Kang C, et al. Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Cancer Biol Ther 2009; 8:1002-9.
27. Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 2003; 13:507-18.
28. Fujiwara K, Iwado E, Mills GB, et al. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int J Oncol 2007; 31:753-60.
29. Nan Y, Han L, Zhang A, et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 2010; 1359:14-21.
30. Honjho Y, Fujiwara T, Nagao S, et al. Analysis of proliferating cell nuclear antigen (PCNA) expression in brain rumors. No Shinkei Geka 1996; 24:143-8.
31. Kayaselçuk F, Zorludemir S, Gümürdühü D, D, Zeren H, Erman T. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neurooncol 2002; 57:115-21.
32. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci 2003; 8:e261-9.
33. Wild-Bode C, Weller M, Wick W. Molecular determinants of glioma cell migration and invasion. J Neurosurg 2001; 94:978-84.
34. Sallinen SL, Sallinen PK, Kononen JT, et al. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis. J Pathol 1999; 188:289-93.